{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:57:42Z","timestamp":1787021862877,"version":"build-2736575974"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T00:00:00Z","timestamp":1334188800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0035501","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T17:09:03Z","timestamp":1334250543000},"page":"e35501","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":76,"title":["Downregulation of Mir-31, Mir-155, and Mir-564 in Chronic Myeloid Leukemia Cells"],"prefix":"10.1371","volume":"7","author":[{"given":"Oshrat","family":"Hershkovitz Rokah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Granot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelina","family":"Ovcharenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Modai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metsada","family":"Pasmanik-Chor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Toren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Shomron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Shpilberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,4,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia.","volume":"96","author":"MW Deininger","year":"2000","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra013339","article-title":"Imatinib mesylate\u2013a new oral targeted therapy.","volume":"346","author":"DG Savage","year":"2002","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.canlet.2010.09.019","article-title":"MicroRNAs, cancer and cancer stem cells.","volume":"300","author":"AL Zimmerman","year":"2011","journal-title":"Cancer Lett"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function.","volume":"116","author":"DP Bartel","year":"2004","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/35002607","article-title":"The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans.","volume":"403","author":"BJ Reinhart","year":"2000","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/nature03816","article-title":"Stem cell division is regulated by the microRNA pathway.","volume":"435","author":"SD Hatfield","year":"2005","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00441-007-0530-3","article-title":"microRNA and stem cell function.","volume":"331","author":"S Hatfield","year":"2008","journal-title":"Cell Tissue Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/nar\/gki200","article-title":"Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis.","volume":"33","author":"AM Cheng","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.","volume":"353","author":"GA Calin","year":"2005","journal-title":"The New England journal of medicine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/435745a","article-title":"Cancer genomics: small RNAs with big impacts.","volume":"435","author":"PS Meltzer","year":"2005","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets.","volume":"103","author":"S Volinia","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","first-page":"1","article-title":"An Evolutionary Perspective of Animal MicroRNAs and Their Targets.","author":"N Shomron","year":"2009"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.leukres.2005.09.001","article-title":"Hematopoietic-specific microRNA expression in human cells.","volume":"30","author":"SH Ramkissoon","year":"2006","journal-title":"Leuk Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers.","volume":"435","author":"J Lu","year":"2005","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/path.2806","article-title":"miRNAs in human cancer.","volume":"223","author":"TA Farazi","year":"2011","journal-title":"J Pathol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.critrevonc.2009.05.001","article-title":"MicroRNA and leukemia: tiny molecule, great function.","volume":"74","author":"H Zhao","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1158\/1541-7786.MCR-08-0167","article-title":"Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+cells increases USF2-mediated cell growth.","volume":"6","author":"X Agirre","year":"2008","journal-title":"Mol Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1182\/blood-2006-09-045104","article-title":"Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+cells.","volume":"109","author":"L Venturini","year":"2007","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1158\/0008-5472.CAN-10-1684","article-title":"Dysregulation of the mitogen granulin in human cancer through the miR-15\/107 microRNA gene group.","volume":"70","author":"WX Wang","year":"2010","journal-title":"Cancer research"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.leukres.2010.08.005","article-title":"MicroRNA microarrays on archive bone marrow core biopsies of leukemias\u2013method validation.","volume":"35","author":"I Borze","year":"2011","journal-title":"Leuk Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00277-010-1072-4","article-title":"Expression of myelopoiesis-associated microRNA in bone marrow cells of atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia.","volume":"90","author":"K Hussein","year":"2011","journal-title":"Ann Hematol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data.","volume":"4","author":"RA Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","article-title":"A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.","volume":"19","author":"BM Bolstad","year":"2003","journal-title":"Bioinformatics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets.","volume":"120","author":"BP Lewis","year":"2005","journal-title":"Cell"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes.","volume":"28","author":"M Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e7439","DOI":"10.1371\/journal.pone.0007439","article-title":"A BCR-ABL mutant lacking direct binding sites for the GRB2, CBL and CRKL adapter proteins fails to induce leukemia in mice.","volume":"4","author":"KJ Johnson","year":"2009","journal-title":"PloS one"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/gcc.20377","article-title":"Detection in primary chronic myeloid leukaemia cells of p210BCR-ABL1 in complexes with adaptor proteins CBL, CRKL, and GRB2.","volume":"45","author":"H Patel","year":"2006","journal-title":"Genes, chromosomes & cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"9540","DOI":"10.1073\/pnas.92.21.9540","article-title":"Signaling by Abl Oncogenes through Cyclin D1.","volume":"92","author":"DEH Afar","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1182\/blood.V97.5.1404","article-title":"Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR\/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia.","volume":"97","author":"DG Peters","year":"2001","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1182\/blood-2007-05-090472","article-title":"Identification of novel posttranscriptional targets of the BCR\/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR\/ABL leukemogenesis.","volume":"111","author":"AM Eiring","year":"2008","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/leu.2010.298","article-title":"A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases.","volume":"25","author":"V Grossmann","year":"2011","journal-title":"Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, UK"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers.","volume":"6","author":"GA Calin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1073\/pnas.0602266103","article-title":"Pre-B cell proliferation and lymphoblastic leukemia\/high-grade lymphoma in E(mu)-miR155 transgenic mice.","volume":"103","author":"S Costinean","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.","volume":"353","author":"GA Calin","year":"2005","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1073\/pnas.0500613102","article-title":"Accumulation of miR-155 and BIC RNA in human B cell lymphomas.","volume":"102","author":"PS Eis","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/path.1825","article-title":"BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas.","volume":"207","author":"J Kluiver","year":"2005","journal-title":"J Pathol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/gcc.20273","article-title":"Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma.","volume":"45","author":"J Kluiver","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"11755","DOI":"10.1073\/pnas.0404432101","article-title":"MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias.","volume":"101","author":"GA Calin","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"D140","DOI":"10.1093\/nar\/gkj112","article-title":"miRBase: microRNA sequences, targets and gene nomenclature.","volume":"34","author":"S Griffiths-Jones","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.cell.2009.03.047","article-title":"A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.","volume":"137","author":"S Valastyan","year":"2009","journal-title":"Cell"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000113489","article-title":"Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer.","volume":"72","author":"O Slaby","year":"2007","journal-title":"Oncology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1601-0825.2009.01646.x","article-title":"Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer.","volume":"16","author":"CJ Liu","year":"2010","journal-title":"Oral Diseases"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1073\/pnas.1019557108","article-title":"MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia.","volume":"108","author":"E Moussay","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref44","first-page":"160","article-title":"The mitogen-activated protein kinase signaling module as a therapeutic target in hematologic malignancies.","volume":"7","author":"M Milella","year":"2003","journal-title":"Reviews in clinical and experimental hematology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network.","volume":"2","author":"Y Yarden","year":"2001","journal-title":"Nature reviews Molecular cell biology"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/10428194.2010.546919","article-title":"Regulation of mammalian target of rapamycin and mitogen activated protein kinase pathways by BCR-ABL.","volume":"52","author":"AJ Redig","year":"2011","journal-title":"Leukemia & lymphoma"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.0960-135X.2004.01365.x","article-title":"Expression of angiogenic factors in chronic myeloid leukaemia: role of the bcr\/abl oncogene, biochemical mechanisms, and potential clinical implications.","volume":"34","author":"C Sillaber","year":"2004","journal-title":"European journal of clinical investigation"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1073\/pnas.0900653106","article-title":"Charting the molecular network of the drug target Bcr-Abl.","volume":"106","author":"M Brehme","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1080\/10428190400003317","article-title":"Overexpression of cyclin D1 in accelerated-phase chronic myeloid leukemia.","volume":"45","author":"JH Liu","year":"2004","journal-title":"Leukemia & lymphoma"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1079-9796(03)00070-6","article-title":"Involvement of Akt kinase in the action of STI571 on chronic myelogenous leukemia cells.","volume":"31","author":"K Kawauchi","year":"2003","journal-title":"Blood cells, molecules & diseases"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.bbrc.2009.12.086","article-title":"Blockade of the ERK or PI3K-Akt signaling pathway enhances the cytotoxicity of histone deacetylase inhibitors in tumor cells resistant to gefitinib or imatinib.","volume":"391","author":"K Ozaki","year":"2010","journal-title":"Biochemical and biophysical research communications"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1073\/pnas.86.4.1168","article-title":"v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas.","volume":"86","author":"WY Langdon","year":"1989","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/mcbr.2000.0231","article-title":"STAT5-Dependent CyclinD1 and Bcl-xL expression in Bcr-Abl-transformed cells.","volume":"3","author":"RP de Groot","year":"2000","journal-title":"Molecular cell biology research communications : MCBRC"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1182\/blood.V73.4.1028.1028","article-title":"Rare occurrence of N-ras point mutations in Philadelphia chromosome positive chronic myeloid leukemia.","volume":"73","author":"SJ Collins","year":"1989","journal-title":"Blood"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/stem.140725","article-title":"Mutations and expression of the ras family genes in leukemias.","volume":"14","author":"DM Gougopoulou","year":"1996","journal-title":"Stem cells"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood.V96.5.1655","article-title":"Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?","volume":"96","author":"CW Reuter","year":"2000","journal-title":"Blood"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1182\/blood-2002-02-0492","article-title":"The roles of FLT3 in hematopoiesis and leukemia.","volume":"100","author":"DG Gilliland","year":"2002","journal-title":"Blood"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.V95.2.726","article-title":"C-kit mutations in core binding factor leukemias.","volume":"95","author":"A Beghini","year":"2000","journal-title":"Blood"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1182\/blood.V93.4.1355","article-title":"Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25).","volume":"93","author":"M Eguchi","year":"1999","journal-title":"Blood"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(01)00245-8","article-title":"NF1 tumor suppressor gene function: narrowing the GAP.","volume":"104","author":"K Cichowski","year":"2001","journal-title":"Cell"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/jnci\/92.15.1252","article-title":"Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis.","volume":"92","author":"M Barlund","year":"2000","journal-title":"Journal of the National Cancer Institute"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"21528","DOI":"10.1074\/jbc.274.31.21528","article-title":"Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines.","volume":"274","author":"K Nakatani","year":"1999","journal-title":"The Journal of biological chemistry"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0035501","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T16:39:43Z","timestamp":1593967183000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0035501"}},"subtitle":[],"editor":[{"given":"K.T.","family":"Jeang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,12]]},"references-count":62,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0035501","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,12]]}}}